Growing evidence reveals that the accumulation of adipose tissue leads to the development of systemic inflammation (e.g. increases in circulating levels of tumor necrosis factor-α and interleukin-6) [37, 38], which accounts for the obesity-associated vasculopathy and cardiovascular risks [39–41]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.